Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones (Q38514840)

3 September 2017

1 reference

title

Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones (English)

1 reference

ORCID Public Data File 2021

3 September 2017

0 references

0 references

1 reference

author name string

Preeshila Behary

1

1 reference

3 September 2017

Jaimini Cegla

2

1 reference

3 September 2017

Tricia M Tan

3

1 reference

3 September 2017

Stephen R Bloom

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

3 September 2017

Postgraduate Medicine

1 reference

3 September 2017

127

1 reference

3 September 2017

5

1 reference

3 September 2017

494-502

1 reference

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

3 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Interdisciplinary European guidelines on metabolic and bariatric surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

The global obesity pandemic: shaped by global drivers and local environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

The evolution of very-low-calorie diets: an update and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effects of low-carbohydrate and low-fat diets: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Micronutrient deficiency in obese subjects undergoing low calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Long-term weight loss after diet and exercise: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Long-term persistence of hormonal adaptations to weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effects of dietary composition on energy expenditure during weight-loss maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Changes in energy expenditure resulting from altered body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Weight loss, weight maintenance, and adaptive thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Biological mechanisms that promote weight regain following weight loss in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effects of reduced weight maintenance and leptin repletion on functional connectivity of the hypothalamus in obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

The role of physical activity in producing and maintaining weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Correlates of adults' participation in physical activity: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Bariatric Surgery Worldwide 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Laparoscopic sleeve gastrectomy compared with other bariatric surgical procedures: a systematic review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Review of long-term weight loss results after laparoscopic sleeve gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effects of Roux-en-Y gastric bypass on energy and glucose homeostasis are preserved in two mouse models of functional glucagon-like peptide-1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

The gut endocrine system as a coordinator of postprandial nutrient homoeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Vagal innervation of intestine contributes to weight loss After Roux-en-Y gastric bypass surgery in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Vagal innervation patterns following Roux-en-Y gastric bypass in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Trends in mortality in bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Bariatric surgery: an IDF statement for obese Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Health inequity in access to bariatric surgery: a protocol for a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Eligibility for bariatric surgery among adults in England: analysis of a national cross-sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Food and Drug Administration's Obesity Drug Guidance Document: a short history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Meta-analysis: pharmacologic treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

The FDA's assessment of two drugs for chronic weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Multicenter, placebo-controlled trial of lorcaserin for weight management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

GLP-1 receptor agonists: a review of head-to-head clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

A critical analysis of the clinical use of incretin-based therapies: The benefits by far outweigh the potential risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Do GLP-1-based therapies increase cancer risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Characterization of the effects of pancreatic polypeptide in the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Pancreatic polypeptide reduces appetite and food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

Peptide therapeutics: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.2015.1048181

10.1080/00325481.2015.1048181

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference